‼️ #MASLD = multisystem disease, global public-health problem. ⚠️ Drives #liver failure, CVD, CKD, T2D & certain cancers. 💊 Urgent need for therapies:.• 2024: #Resmetirom → 1st FDA-approved drug for #MASH w/ fibrosis. • #GLP1 & metabolic agents show promise beyond liver. 👇🏼🔗

HOSPITAL PROTOCOLS THAT M_RDER WITH DEATH ROW PRISONER DRUGS:. — Lorazepam, Diazepam, or Versed.— Propofol, Precedex, or Thiopental.— Opioids: Fentanyl, Morphine . AND THEN THERE’S KIDNEY FAILURE OR MULTISYSTEM ORGAN FAILURE:. — Remdesivir/Veklury. DON’T FORGET THAT VENTILATORS

We’ve nearly completed Level 1 and will be releasing the order numbers for the next levels as we get closer to them. We are ramping up both speed and volume, so stay calm and game on!. If you want a Multisystem2, please jump into the pre-order queue, we are building more, thanks!

🧵 #SpinTweetorialWednesday.🎯 Woodhouse-Sakati Syndrome (WSS).A rare, autosomal recessive multisystem disorder that uniquely marries neuroendocrine, dermatologic, and neurodegenerative features — and leaves unmistakable marks on the brain MRI. Let's break it down. 👇

A new review discusses the global clinical burden and consequences of MASLD as a multisystem disease and focuses on the new and promising metabolism-based pharmacotherapies targeting the liver and coexisting cardiovascular–kidney–metabolic conditions of MASLD. Full review:

🦋 Think Lupus Early. Multisystem symptoms? Fatigue + rash + cytopenias?.SLE can mimic anything. Catch the clues in primary care before it flares dangerously. #SLE #Rheumatology #MedTwitter @IhabFathiSulima @Lupusreference @lupuscyclopedia @LupusResearch @LupusChannel

Our commentary is now available on @LancetRH_WPac Multisystem burden in cirrhosis: lessons from a marginalised population.@docamitgs @JVLazarus

First IACC/PAIS, now PAIVS, and still no mention of ICD-10 ⤵️. U10.9: Multisystem inflammatory syndrome due to COVID-19. Even when it affects children, they won’t call it what it is. This is more than bad framing. It’s institutional gaslighting.

Pediatric Gastrointestinal Disorders in Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated With COVID‐19: A Case Series - di Toma - 2025 - Case Reports in Pediatrics

Thank you for your amazing support and enthusiasm for the #Multisystem2. We know lots of you are keen to know when to expect your order. We’ve created some 'Shipping game' levels to help give you an idea of where your order is in the shipping process.

Aujourd’hui, on plonge dans l annonce du nouveau MiSTer Multisystem 2 FPGA annoncé pour aout 2025 , une console rétro qui promet une expérience 100% fidèle aux machines d’époque ! h https://youtu.be/nqtIBwYlMZ8

Inflammatory Bowel Disease (IBD) and LC and ME/CFS: Correlation or Causation?. IBD shares striking clinical and immunological features with Long Covid (LC) and ME/CFS. Are overlapping mechanisms driving multisystem symptom expression across these conditions?

Meet the team at @pepcleveland #PEPConnections! This team of Community Care Coordinators work with young people whose mental health and multisystem needs impact their ability to thrive within their school, home, and their communities. Strengthening Minds with Heart!

Pfizer statement to FDA, prior to EU authorization of Pfizer-Covid-19 mRNA vaccine for children aged 5-11 years: . "No severe cases of COVID-19 or multisystem inflammatory syndrome in children, were reported in either group (vaccine vs placebo), when delta variant was in

This study summarizes key histologic findings from muscle biopsies of patients with valosin-containing protein multisystem proteinopathy: #NeuroGenetics #NeuroX

Today, we honor the lives of those living with Severe Myalgic Encephalomyelitis (ME/CFS). This multisystem biological illness devastates lives and remains dangerously under-researched. At CODA, we see you. We believe you. We are fighting for the science and support you deserve.

Friedreich's ataxia—a rare multisystem disease.

Metabolic Dysfunction–Associated Steatotic Liver Disease. MASLD is a multisystem disease that has become a public-health problem worldwide. Metabolic dysfunction is key to the pathogenesis and consequences of MASLD. The clinical burden of MASLD consists mainly of liver-related

New Horizons in Systemic Sclerosis treatment: advances and emerging therapies in 2025 ⭐. Systemic sclerosis (SSc) remains one of the most complex autoimmune diseases to treat, with multisystem involvement and limited therapeutic options. This review charts the shift from broad